Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
about
Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@en
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@nl
type
label
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@en
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@nl
prefLabel
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@en
Dihydroergotamine inhibits the ...... noceptors and 5-HT1 receptors.
@nl
P2860
P50
P1476
Dihydroergotamine inhibits the ...... enoceptors and 5-HT1 receptors
@en
P2093
Antoinette MaassenVanDenBrink
P2860
P2888
P356
10.1186/S10194-018-0869-8
P577
2018-05-25T00:00:00Z
P6179
1104237769